Addex Therapeutics Ltd
SIX:ADXN

Watchlist Manager
Addex Therapeutics Ltd Logo
Addex Therapeutics Ltd
SIX:ADXN
Watchlist
Price: 0.0564 CHF 2.92% Market Closed
Market Cap: 10.4m CHF

Intrinsic Value

ADXN doesn't have a meaningful market cap.

The intrinsic value of one ADXN stock under the Base Case scenario is 0.0356 CHF. Compared to the current market price of 0.0564 CHF, Addex Therapeutics Ltd is Overvalued by 37%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ADXN Intrinsic Value
0.0356 CHF
Overvaluation 37%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Addex Therapeutics Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about ADXN?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is ADXN valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Addex Therapeutics Ltd.

Explain Valuation
Compare ADXN to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ADXN?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Addex Therapeutics Ltd

Current Assets 2.4m
Cash & Short-Term Investments 2.2m
Receivables 51.3k
Other Current Assets 119.3k
Non-Current Assets 5m
Long-Term Investments 4.4m
PP&E 36.4k
Other Non-Current Assets 516.1k
Current Liabilities 1.2m
Accounts Payable 406.1k
Accrued Liabilities 761.2k
Other Current Liabilities 7.6k
Non-Current Liabilities 197.4k
Long-Term Debt 29k
Other Non-Current Liabilities 168.4k
Efficiency

Free Cash Flow Analysis
Addex Therapeutics Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Addex Therapeutics Ltd

Revenue
555.2k CHF
Operating Expenses
-2.6m CHF
Operating Income
-2.1m CHF
Other Expenses
-3.6m CHF
Net Income
-5.7m CHF
Fundamental Scores

ADXN Profitability Score
Profitability Due Diligence

Addex Therapeutics Ltd's profitability score is 18/100. The higher the profitability score, the more profitable the company is.

18/100
Profitability
Score

Addex Therapeutics Ltd's profitability score is 18/100. The higher the profitability score, the more profitable the company is.

ADXN Solvency Score
Solvency Due Diligence

Addex Therapeutics Ltd's solvency score is 51/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Negative Net Debt
Low D/E
Short-Term Solvency
51/100
Solvency
Score

Addex Therapeutics Ltd's solvency score is 51/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ADXN Price Targets Summary
Addex Therapeutics Ltd

There are no price targets for ADXN.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Addex Therapeutics Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for ADXN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one ADXN stock?

The intrinsic value of one ADXN stock under the Base Case scenario is 0.0356 CHF.

Is ADXN stock undervalued or overvalued?

Compared to the current market price of 0.0564 CHF, Addex Therapeutics Ltd is Overvalued by 37%.

Back to Top